Leukemia cell being destroyed
Researchers find early clues that point to leukemia development

Finding cancer before it grows and spreads is usually important in treating it successfully. But some cancers don’t have noticeable symptoms, making it difficult to diagnose them early.

Innovative in science and medicine
Genetic research tailors treatment for kidney cancer

One challenge that doctors face when treating people with cancer is that they may respond very differently to treatment. Even in people with the same type of cancer, the same treatment may cause some to have their disease completely disappear, while having only a partial response or no effect in others. If researchers can find out how to identify who will benefit from a particular treatment, they will be able to target the use of these treatments and only offer them to people who will benefit.

Your trusted source for the most up-to-date cancer statistics in Canada

For more than 30 years, Canadian Cancer Statistics has provided comprehensive, up-to-date cancer statistics for Canada. Developed collaboratively by the Canadian Cancer Society, Public Health Agency of Canada and Statistics Canada, a special report on cancer incidence by stage was released June 13, 2018.

screenshot from video showing doctor and patient
How the HPV vaccine works

Watch video

animation of a CAR-T cell interacting with a target protein on a cancer cell
How CAR-T cells work to fight cancer

Watch video

cartoon of cancer stem cell resisting treatment
The challenges behind the fight against cancer

Watch video

New approach reduces radiation risks for patients with breast cancer

An international study has shown that partial radiation of the breast reduces a patient’s long-term risk of developing cancer in other areas such as the esophagus, colon and lung. The partial treatment approach is just as effective as whole-breast radiation in treating breast cancer but offers fewer side effects. This is especially important as patients with breast cancer are diagnosed and treated earlier and living longer. Learn more in an article from CBC News.

Plain tobacco packaging coming to Canada

Smoking is a major cause of lung cancer and remains a major target for cancer prevention. With several policies regulating cigarette smoking in public places, the government of Canada has passed Bill S-5, which gives Health Canada authority to regulate vaping or e-cigarette use and an opportunity to pursue a plain packaging strategy for cigarettes. Learn more in an article from CBC News.

Cancer gene overpowers others to drive brain cancer

Children with high-risk brain cancer have a low survival rate and researchers are looking at cancer genes to understand why this might be. Using advanced genetic tests, a team of researchers from Memphis and Boston have identified a cancer gene that could be hijacking a cell’s DNA to promote cancer growth. This research could aid in the development of precision medicine to treat these children. Learn more in an article from St. Jude’s Children’s Research Hospital.

Improving care for teens and young adults with cancer

Adolescents and young adults with cancer face unique challenges that, until recently, were not addressed by existing healthcare and medical practices. These needs, which include concerns about fertility, sexuality, body image, education and career, were not being met by pediatric or adult facilities, leading many patients to fall through the cracks. Thanks to patient advocates, this is slowly changing. Many hospitals now have special programs and units designed specifically to help teens and…

New treatment shows promise for terminal ovarian and lung cancers

Early results from a clinical trial has shown that a new treatment strategy can extend the lives of patients with advanced ovarian or lung cancers. The combination of the targeted drug vistusertib and the chemotherapy drug paclitaxel halted tumour growth for nearly six months and caused the tumours to shrink in some patients. All patients in the trial had advanced disease and did not respond to standard treatment. Read more in an article from The Guardian.

Slowing skin cancer that has spread to the brain

A new study has shown that a combination of two immunotherapy drugs can shrink brain tumours in patients with melanoma whose cancer had spread from their skin to the brain. The drugs, which are called checkpoint inhibitors, work by activating the immune system to attack brain cancer cells. Among cancers, melanoma is one of the most likely ones to spread to the brain. In patients whose cancer has spread, fewer than 20% will survive 1 year with standard treatments. Among the patients in the study…